Haemonetics ( (HAE) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Haemonetics shares experienced a downturn despite reporting better-than-expected Q2 earnings and revenue, as the company adjusted its FY26 revenue outlook to reflect a more cautious growth approach amid market dynamics. This led to a lowered price target, although strategic adjustments and strong segment performance suggest a positive future outlook.
More about Haemonetics
YTD Price Performance: -35.31%
Average Trading Volume: 1,007,014
Technical Sentiment Signal: Sell
Current Market Cap: $2.43B
For further insights into HAE stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.